December 2018 - Evolution Biotechnologies
archive,date,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-16.4,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Bedford, UK, December 15th 2018 Evolution Biotechnologies (, the UK and US-based company pioneering the use of biological control in human disease, today announces the appointment of Mr. Edward C. Cappabianca as Chief Business Officer. Mr. Cappabianca has a strong background in investment banking, previously working with Alex. Brown & Sons, William Blair International, and Rodman & Renshaw, LLC. He also has operational management experience in the Biotech & Life Sciences sector having served as CEO of AmpliPhi Biosciences in the US and Founding CEO of EnXray in the UK. Mr. Cappabianca said “I am very pleased to join Evolution as a...